Download or read book The Licensing Agreement in Pharmaceutical Business Development 3rd edition written by and published by Pharmalicensing. This book was released on with total page 61 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Pharmaceutical Licensing Strategies written by Steven Seget and published by . This book was released on 2006 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: With falling R&D productivity, continued healthcare cost containment and the threat of generic competition, only companies who combine internal efforts with effective licensing strategies will remain competitive over the next five to ten years.

Download or read book Licensing Strategies and Performance written by Kathleen R. Whitney and published by . This book was released on 1991 with total page 532 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Maximizing Pharmaceutical Licensing Opportunities written by Tim Wesley and published by . This book was released on 2011 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: As pharma majors continue to trim in-house costs and realign their businesses to fit an increasingly challenging market environment, a growing number of Big Pharma CEOs favor licensing agreements and alliances, as more flexible growth strategies.

Download or read book Licensing Best Practices written by Robert Goldscheider and published by John Wiley & Sons. This book was released on 2002-10-29 with total page 528 pages. Available in PDF, EPUB and Kindle. Book excerpt: A definitive resource for professionals in licensing and technologymanagement In this comprehensive guide to licensing best practices, esteemedmembers of the Licensing Executives Society International offerin-depth discussion of a broad range of important topics in thefield of licensing, including: * Licensing issues in Europe, Asia, Australia, the Middle East,South Africa, and Latin America * Technology valuation * Technology management consulting * Licensing agreements and strategic partnerships * The expansion of the licensing profession * Patent procedures and protection in Europe * Trade secrets law and intellectual property assets * Issues in copyright, software, and Web sites * Trademarks, trade names, and trade dress * Licensing in the biotechnology industry * Pharmaceutical licensing * University licensing trends * Technology rights that are financial assets and instruments * IC-based corporate carve-outs * Licensing and litigation * ADR

Download or read book Pharmaceutical Licensing Strategies written by Stephen Seget and published by . This book was released on 2013 with total page 116 pages. Available in PDF, EPUB and Kindle. Book excerpt: With falling R&D productivity, continued healthcare cost containment and the threat of generic competition, only companies who combine internal efforts with effective licensing strategies will remain competitive over the next five to ten years.

Download or read book Licensing Strategies written by and published by . This book was released on 2003 with total page 177 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Creating Win win Biotechnology and Pharmaceutical Deals written by Datamonitor (Firm) and published by . This book was released on 2000 with total page 268 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Strategic Guide to Pharmaceutical Licensing written by Gregg Clopath and published by . This book was released on 2008 with total page 112 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Pharma Strategies written by R. Mishra and published by . This book was released on 2008 with total page 16 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Forest Laboratories Schering Plough Case Studies Pharmaceutical Licensing Strategies written by and published by . This book was released on with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book An Analysis of Optimal Licensing Strategies at the Pharma Biotech Interface written by Anne-Marie Samuel and published by . This book was released on 2003 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Business Development for the Biotechnology and Pharmaceutical Industry written by Martin Austin and published by CRC Press. This book was released on 2016-04-08 with total page 202 pages. Available in PDF, EPUB and Kindle. Book excerpt: Business Development in the biotechnology and pharmaceutical industries accounts for over $5 billion in licensing deal value per year and much more than that in the value of mergers and acquisitions. Transactions range from licences to patented academic research, to product developments as licences, joint ventures and acquisition of intellectual property rights, and on to collaborations in development and marketing, locally or across the globe. Asset sales, mergers and corporate takeovers are also a part of the business development remit. The scope of the job can be immense, spanning the life-cycle of products from the earliest levels of research to the disposal of residual marketing rights, involving legal regulatory manufacturing, clinical development, sales and marketing and financial aspects. The knowledge and skills required of practitioners must be similarly broad, yet the availability of information for developing a career in business development is sparse. Martin Austin's highly practical guide spans the complete process and is based on his 30 years of experience in the industry and the well-established training programme that he has developed and delivers to pharmaceutical executives from across the world.

Download or read book Maximizing Pharmaceutical Licensing Opportunities written by Tim Wesley and published by . This book was released on 2013 with total page 153 pages. Available in PDF, EPUB and Kindle. Book excerpt: As pharma majors continue to trim in-house costs and realign their businesses to fit an increasingly challenging market environment, a growing number of Big Pharma CEOs favor licensing agreements and alliances, as more flexible growth strategies.

Download or read book Leading Pharmaceutical Innovation written by Oliver Gassmann and published by Springer Science & Business Media. This book was released on 2008-02-19 with total page 194 pages. Available in PDF, EPUB and Kindle. Book excerpt: Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.

Download or read book The Pharmaceutical Licensing Outlook written by Stephen Seget and published by . This book was released on 2002 with total page 420 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Licensing Selling and Finance in the Pharmaceutical and Healthcare Industries written by Martin Austin and published by Routledge. This book was released on 2016-05-06 with total page 191 pages. Available in PDF, EPUB and Kindle. Book excerpt: Licensing, Selling and Finance in the Pharmaceutical and Healthcare Industries is an assessment of the turbulent state of pharmaceutical and biotechnology markets as we enter the second decade of the 21st Century. At the same time, the book offers a cautionary evaluation of the future financing of innovation in terms of what's gone wrong and how to succeed in the future. Martin Austin explores the challenge that the pharmaceutical (and related) industries face in terms of balancing short term, cost containment and expenditure control in areas such as internal research and development; whilst embracing in-licensing and the acquisition of innovative therapies to counteract their impending portfolio weaknesses in the mid to longer term. The first part of the book provides an engaging and convincing perspective on the context in which the industry currently finds itself; the second part is a pragmatic guide to commercialising your intellectual property; including how to recognise and value what you have as well as the new ways of working that you will need to adopt when negotiating, collaborating and contracting in partnership and alliance with others. Commentators have described in great detail the cocktail of commercial, clinical and social issues that threaten to overwhelm the pharmaceutical industry; Martin Austin's book offers a very distinctive perspective on these issues and their solution.